1887
  1. Home
  2. Eurosurveillance
  3. Volume 30, Issue 11, 20/Mar/2025
  4. Article
Research Open Access
Like 0
Download

SDG 3: Tuberculosis

Abstract

Background

As tuberculosis (TB) incidence rates decrease faster in native than migrant populations in European countries, addressing migrant health becomes increasingly important in TB programmes.

Aim

To inform European TB prevention and control policies, we analysed data on TB in migrants in low TB-incidence European countries (TB incidence < 10/100,000 population) during 2014–2020 by migrant origin, destination, and recent vs non-recent immigration.

Methods

Data on migrant TB patients were derived from the European Surveillance System (TESSy) and data on migrant populations from Eurostat or national statistical offices. We calculated annual migrant TB crude incidence rates (CIRs) per country of origin, destination country and year, for all migrants with TB and recently arrived migrants with TB, the latter defined by TB diagnosis within 1 year after arrival in the destination country.

Results

In 2014–2020, 104,371 migrants with TB were reported to TESSy by 20 destination countries. Average annual migrant CIRs were highest in the United Kingdom (43/100,000). Origin countries of most migrant TB patients were India (n = 9,561), Romania (n = 8,345), and Pakistan (n = 7,300). The highest CIRs were found among migrants from Eritrea (480/100,000), Somalia (414/100,000) and The Gambia (343/100,000), and were higher than estimated World Health Organization incidences for those countries. The CIRs among recently arrived migrants appeared higher than in the overall migrant population.

Conclusions

We found substantially higher CIRs in certain migrant subpopulations than others. TB rates in recent migrants appeared to be up to 11 times higher than in corresponding origin countries. Tailored and regularly adapted TB prevention and control strategies are needed.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.11.2400489
2025-03-20
2025-03-23
/content/10.2807/1560-7917.ES.2025.30.11.2400489
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/11/eurosurv-30-11-4.html?itemId=/content/10.2807/1560-7917.ES.2025.30.11.2400489&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). Global Tuberculosis Report 2023. Geneva: WHO; 2023.
  2. Lönnroth K, Mor Z, Erkens C, Bruchfeld J, Nathavitharana RR, van der Werf MJ, et al. Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points. Int J Tuberc Lung Dis. 2017;21(6):624-37.  https://doi.org/10.5588/ijtld.16.0845  PMID: 28482956 
  3. European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2024 – 2022 data. Stockholm: ECDC; 2024.
  4. Slump E, Anthony R, Kamst-van Agterveld MP, Mulder AC, Schimmel HJ, Stempher E, et al. Tuberculosis in the Netherlands 2022. Surveillance and monitoring of interventions report. Bilthoven: RIVM; 2023.
  5. Nordstrand K, Arnesen T, Mengshoel A, Strand A, Ingebrigtsen T, Heldal E, et al. “Tuberkulose i Norge 2022 – med behandlingsresultater for 2021’ [Tuberculosis in Norway 2022 – with treatment results for 2021 ]. Annual report. Oslo: Norwegian Institute of Public Health; 2023.
  6. Collin SM, de Vries G, Lönnroth K, Migliori GB, Abubakar I, Anderson SR, et al. Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes. Eur Respir J. 2018;52(6):1801449.  https://doi.org/10.1183/13993003.01449-2018  PMID: 30309977 
  7. Hayward S, Harding RM, McShane H, Tanner R. Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK. F1000 Res. 2018;7:461.  https://doi.org/10.12688/f1000research.14476.2  PMID: 30210785 
  8. Menzies NA, Hill AN, Cohen T, Salomon JA. The impact of migration on tuberculosis in the United States. Int J Tuberc Lung Dis. 2018;22(12):1392-403.  https://doi.org/10.5588/ijtld.17.0185  PMID: 30606311 
  9. World Health Organization (WHO). WHO consolidated guidelines on tuberculosis (Module 1 Prevention). Tuberculosis preventive treatment. Geneva: WHO; 2020. Report No.: WHO/HTM/TB/2017.04.
  10. Jackson S, Kabir Z, Comiskey C. Effects of migration on tuberculosis epidemiological indicators in low and medium tuberculosis incidence countries: A systematic review. J Clin Tuberc Other Mycobact Dis. 2021;23:100225.  https://doi.org/10.1016/j.jctube.2021.100225  PMID: 33681478 
  11. Zenner D, Brals D, Nederby-Öhd J, Menezes D, Aldridge R, Anderson SR, et al. Drivers determining tuberculosis disease screening yield in four European screening programmes: a comparative analysis. Eur Respir J. 2023;62(4):2202396.  https://doi.org/10.1183/13993003.02396-2022  PMID: 37230498 
  12. Kristensen KL, Ravn P, Petersen JH, Hargreaves S, Nellums LB, Friedland JS, et al. Long-term risk of tuberculosis among migrants according to migrant status: a cohort study. Int J Epidemiol. 2020;49(3):776-85.  https://doi.org/10.1093/ije/dyaa063  PMID: 32380550 
  13. Hayward SE, Rustage K, Nellums LB, van der Werf MJ, Noori T, Boccia D, et al. Extrapulmonary tuberculosis among migrants in Europe, 1995 to 2017. Clin Microbiol Infect. 2021;27(9):1347.e1-7.  https://doi.org/10.1016/j.cmi.2020.12.006  PMID: 33352301 
  14. Kunst H, Burman M, Arnesen TM, Fiebig L, Hergens MP, Kalkouni O, et al. Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results. Int J Tuberc Lung Dis. 2017;21(8):840-51.  https://doi.org/10.5588/ijtld.17.0036  PMID: 28786791 
  15. Braga S, Vieira M, Barbosa P, Ramos JP, Duarte R. Tuberculosis screening in the European migrant population: a scoping review of current practices. Breathe (Sheff). 2024;20(1):230357.  https://doi.org/10.1183/20734735.0357-2023  PMID: 38746905 
  16. de Vries G, van Rest J, Meijer W, Wolters B, van Hest R. Low yield of screening asylum seekers from countries with a tuberculosis incidence of <50 per 100 000 population. Eur Respir J. 2016;47(6):1870-2.  https://doi.org/10.1183/13993003.00099-2016  PMID: 26965289 
  17. van de Berg S, Erkens C, van Rest J, van den Hof S, Kamphorst M, Keizer S, et al. Evaluation of tuberculosis screening of immigrants in the Netherlands. Eur Respir J. 2017;50(4):1700977.  https://doi.org/10.1183/13993003.00977-2017  PMID: 29025892 
  18. Eurostat. webadres Eurostat. Available from: http://epp.eurostat.ec.europa.eu/portal/page/portal/eurostat/home/
  19. Spruijt I, Erkens C, Greenaway C, Mulder C, Raviglione M, Villa S, et al. Reducing the burden of TB among migrants to low TB incidence countries. Int J Tuberc Lung Dis. 2023;27(3):182-8.  https://doi.org/10.5588/ijtld.22.0662  PMID: 36855037 
  20. Vasiliu A, Köhler N, Altpeter E, Ægisdóttir TR, Amerali M, de Oñate WA, et al. , TBnet. Tuberculosis incidence in foreign-born people residing in European countries in 2020. Euro Surveill. 2023;28(42):2300051.  https://doi.org/10.2807/1560-7917.ES.2023.28.42.2300051  PMID: 37855907 
  21. European Comission. Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. 2018. Available from: https://eur-lex.europa.eu/eli/dec_impl/2018/945/oj
  22. Global Tuberculosis Reports. [Accessed 25 Oct 2024]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports
  23. R Core Team. R: A Language and Environment for Statistical Computing | BibSonomy. 2021 [Accessed 28 Oct 2024]. Available from: https://www.bibsonomy.org/bibtex/7469ffee3b07f9167cf47e7555041ee7
  24. Dhavan P, Dias HM, Creswell J, Weil D. An overview of tuberculosis and migration. Int J Tuberc Lung Dis. 2017;21(6):610-23.  https://doi.org/10.5588/ijtld.16.0917  PMID: 28482955 
  25. Surveillance and updates for tuberculosis. 2010. [Accessed 28 Oct 2024]. Available from: https://www.ecdc.europa.eu/en/tuberculosis/surveillance
  26. Ködmön C, Zucs P, van der Werf MJ. Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013. Euro Surveill. 2016;21(12):30164.  https://doi.org/10.2807/1560-7917.ES.2016.21.12.30164  PMID: 27039665 
  27. Dale KD, Karmakar M, Snow KJ, Menzies D, Trauer JM, Denholm JT. Quantifying the rates of late reactivation tuberculosis: a systematic review. Lancet Infect Dis. 2021;21(10):e303-17.  https://doi.org/10.1016/S1473-3099(20)30728-3  PMID: 33891908 
  28. Willemstein IJM, de Vries G, Essink DR, Slump E, van Gageldonk-Lafeber AB, van den Hof S, et al. TB in migrants residing in the Netherlands for at least 5 years at diagnosis, 2003-2018. Int J Tuberc Lung Dis. 2022;26(11):1050-7.  https://doi.org/10.5588/ijtld.22.0082  PMID: 36281056 
  29. Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD, van der Werf MJ, et al. , MDR-TB Cluster Consortium. A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. Lancet Infect Dis. 2018;18(4):431-40.  https://doi.org/10.1016/S1473-3099(18)30004-5  PMID: 29326013 
  30. Langholz Kristensen K, Lillebaek T, Holm Petersen J, Hargreaves S, Nellums LB, Friedland JS, et al. Tuberculosis incidence among migrants according to migrant status: a cohort study, Denmark, 1993 to 2015. Euro Surveill. 2019;24(44):1900238.  https://doi.org/10.2807/1560-7917.ES.2019.24.44.1900238  PMID: 31690363 
  31. Kunst H, Burman M, Arnesen TM, Fiebig L, Hergens MP, Kalkouni O, et al. Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results. Int J Tuberc Lung Dis. 2017;21(8):840-51.  https://doi.org/10.5588/ijtld.17.0036  PMID: 28786791 
  32. Menezes D, Zenner D, Aldridge R, Anderson SR, de Vries G, Erkens C, et al. Country differences and determinants of yield in programmatic migrant TB screening in four European countries. Int J Tuberc Lung Dis. 2022;26(10):942-8.  https://doi.org/10.5588/ijtld.22.0186  PMID: 36163670 
  33. Nederby Öhd J, Hergens MP, Luksha Y, Buxbaum C, Shedrawy J, Jonsson J, et al. Evaluation of the latent tuberculosis screening and treatment strategy for asylum seekers in Stockholm, Sweden 2015-2018: a record linkage study of the care cascade. Eur Respir J. 2021;57(3):2002255.  https://doi.org/10.1183/13993003.02255-2020  PMID: 32855227 
  34. Spruijt I, Joren C, van den Hof S, Erkens C. Tailored approaches facilitate high completion of tuberculosis infection treatment among migrants. Eur Respir J. 2022;59(3):2102077.  https://doi.org/10.1183/13993003.02077-2021  PMID: 34561296 
  35. Foreign population by place of birth and selected citizenships. [Accessed 29 Feb 2024]. Available from: https://www.destatis.de/EN/Themes/Society-Environment/Population/Migration-Integration/Tables/foreigner-place-of-birth.html
Tuberculosis rates in migrants in low-incidence European countries, according to country of origin, reporting country and recency of immigration, 2014 to 2020
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Teresa+Domaszewska&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Domaszewska Teresa</a>, <a href="/search?value1=Anders+Koch&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Koch Anders</a>, <a href="/search?value1=Sarah+Jackson&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Jackson Sarah</a>, <a href="/search?value1=Brit+H%C3%A4cker&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Häcker Brit</a>, <a href="/search?value1=Jerker+Jonsson&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Jonsson Jerker</a>, <a href="/search?value1=Kristina+Langholz+Kristensen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Langholz Kristensen Kristina</a>, <a href="/search?value1=Hanna+Soini&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Soini Hanna</a>, <a href="/search?value1=Wouter+Arrazola+de+O%C3%B1ate&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Arrazola de Oñate Wouter</a>, <a href="/search?value1=Jean-Paul+Guthmann&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Guthmann Jean-Paul</a>, <a href="/search?value1=Barbara+Hauer&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hauer Barbara</a>, <a href="/search?value1=Mary+O%C2%B4Meara&option1=author&noRedirect=true" class="nonDisambigAuthorLink">O´Meara Mary</a>, <a href="/search?value1=Karine+Nordstrand&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Nordstrand Karine</a>, <a href="/search?value1=Vinciane+Sizaire&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sizaire Vinciane</a>, <a href="/search?value1=Gerard+de+Vries&option1=author&noRedirect=true" class="nonDisambigAuthorLink">de Vries Gerard</a></span>. Tuberculosis rates in migrants in low-incidence European countries, according to country of origin, reporting country and recency of immigration, 2014 to 2020. <a href="/content/ecdc">Euro Surveill.</a> 2025;30(11):pii=2400489. <a href="https://doi.org/10.2807/1560-7917.ES.2025.30.11.2400489" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2025.30.11.2400489</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 23 Jul 2024;&nbsp;&nbsp; <span class="generated">Accepted</span>: 16 Nov 2024 </span> </p>
/content/10.2807/1560-7917.ES.2025.30.11.2400489
/content/10.2807/1560-7917.ES.2025.30.11.2400489
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error